Selected article for: "function impairment and renal replacement therapy"
Author: Diniz, Lúcio Ricardo Leite; Elshabrawy, Hatem A.; Souza, Marilia Trindade de Santana; Duarte, Allana Brunna Sucupira; Datta, Sabarno; de Sousa, Damião Pergentino
Title: Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury
  • Cord-id: rml4qa56
  • Document date: 2021_9_30
    • ID: rml4qa56
    Snippet: Data obtained from several intensive care units around the world have provided substantial evidence of the strong association between impairment of the renal function and in-hospital deaths of critically ill COVID-19 patients, especially those with comorbidities and requiring renal replacement therapy (RRT). Acute kidney injury (AKI) is a common renal disorder of various etiologies characterized by a sudden and sustained decrease of renal function. Studies have shown that 5–46% of COVID-19 pat
    Document: Data obtained from several intensive care units around the world have provided substantial evidence of the strong association between impairment of the renal function and in-hospital deaths of critically ill COVID-19 patients, especially those with comorbidities and requiring renal replacement therapy (RRT). Acute kidney injury (AKI) is a common renal disorder of various etiologies characterized by a sudden and sustained decrease of renal function. Studies have shown that 5–46% of COVID-19 patients develop AKI during hospital stay, and the mortality of those patients may reach up to 100% depending on various factors, such as organ failures and RRT requirement. Catechins are natural products that have multiple pharmacological activities, including anti-coronavirus and reno-protective activities against kidney injury induced by nephrotoxic agents, obstructive nephropathies and AKI accompanying metabolic and cardiovascular disorders. Therefore, in this review, we discuss the anti-SARS-CoV-2 and reno-protective effects of catechins from a mechanistic perspective. We believe that catechins may serve as promising therapeutics in COVID-19-associated AKI due to their well-recognized anti-SARS-CoV-2, and antioxidant and anti-inflammatory properties that mediate their reno-protective activities.

    Search related documents:
    Co phrase search for related documents
    • accompany metabolic and acute kidney injury: 1
    • ace expression and activity ace expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ace expression and activity ace expression increase: 1, 2
    • ace expression and acute aki kidney injury: 1
    • ace expression and acute kidney injury: 1, 2
    • ace expression and acute renal failure: 1
    • ace expression and acute renal injury: 1
    • ace expression and acute respiratory sars cov syndrome cov: 1
    • ace inhibitor and activity ace expression: 1, 2
    • ace inhibitor and activity ace expression increase: 1
    • ace inhibitor and acute aki kidney injury: 1, 2, 3
    • ace inhibitor and acute kidney injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory sars cov syndrome cov: 1
    • active analog and acute respiratory sars cov syndrome cov: 1